Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support; The New York Times, June 25, 2025

Stephanie Nolen , The New York Times; Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support

"This was supposed to be a breakthrough year in the 44-year-long struggle against H.I.V.

Decades of research and investment produced new approaches to vaccines that were going into their first significant clinical trials.

The hunt for a cure was homing in on key mechanisms to block the virus, which can lurk dormant and near-untraceable in the body for years.

Most critically, a breakthrough preventive drug, lenacapavir, a twice-yearly injection that offers total protection from H.I.V., was to be rapidly rolled out across eastern and southern Africa. The main target: young women. About 300,000 of them were newly infected with the virus last year — half of all new infections worldwide.

Every one of these plans has been derailed by the Trump administration’s slashing of foreign assistance."

US experts fear all vaccines at risk as Trump officials target mRNA jabs; The Guardian, June 14, 2025

Melody Schreiber, The Guardian ; US experts fear all vaccines at risk as Trump officials target mRNA jabs

[Kip Currier: How tragic that so many will suffer preventable ailments and some will die needlessly because of vaccine misinformation and disinformation and conspiracy theories fueled by quack science.]

[Excerpt]

"As top US health officials turn against some mRNA vaccines, experts fear for the country’s preparedness for the next pandemic and worry that other vaccines will be targeted next.

Donald Trump’s administration recently canceled a $766m award to Moderna on the research and development of H5N1 bird flu vaccines, and officials have announced new restrictions and regulations for Covid mRNA vaccines – actions that signal a move away from the breakthrough technology.

These changes add to other vaccine-related shakeups at health agencies, including layoffs and resignations of top vaccine officials and the abrupt termination of HIV vaccine research.

On Monday, Robert F Kennedy Jr, secretary of health and human services, announced he was disbanding the independent advisory committee on vaccines for the US Centers for Disease Control and Prevention (CDC).

“I think mRNA vaccines are particularly at risk, although I think all vaccines are at risk,” said Paul Offit, professor of pediatrics at the University of Pennsylvania Perelman School of Medicine.

“I think that this administration will do everything it can to make vaccines less available, less affordable and more feared.”"